Counter prescription of simvastatin: the views of community pharmacists

J. Howell; David Brown

doi:10.1211/096176706778387161

Counter prescription of simvastatin: the views of community pharmacists

J. Howell, David Brown

Research output: Contribution to journal › Article › peer-review

Abstract

Focal Points ■ Pharmacists’ reasons for not being in favour of the over-the-counter (OTC) statin were multifactorial and provide indications of how their misgivings might be addressed ■ Provision of a satisfactory and convincing evidence base might improve acceptance by the pharmaceutical community, of future prescription – only medicine (POM) to pharmacy medicine (P) switches

Original language	English
Pages (from-to)	B49-B50
Journal	International Journal of Pharmacy Practice
Volume	14
Issue number	S2
DOIs	https://doi.org/10.1211/096176706778387161
Publication status	Published - Sept 2006

Access to Document

10.1211/096176706778387161

Cite this

@article{a540a404675f42c88cf070d0df056014,

title = "Counter prescription of simvastatin: the views of community pharmacists",

abstract = "Focal Points ■ Pharmacists{\textquoteright} reasons for not being in favour of the over-the-counter (OTC) statin were multifactorial and provide indications of how their misgivings might be addressed ■ Provision of a satisfactory and convincing evidence base might improve acceptance by the pharmaceutical community, of future prescription – only medicine (POM) to pharmacy medicine (P) switches",

author = "J. Howell and David Brown",

year = "2006",

month = sep,

doi = "10.1211/096176706778387161",

language = "English",

volume = "14",

pages = "B49--B50",

journal = "International Journal of Pharmacy Practice",

issn = "2042-7174",

publisher = "Oxford University Press",

number = "S2",

}

TY - JOUR

T1 - Counter prescription of simvastatin: the views of community pharmacists

AU - Howell, J.

AU - Brown, David

PY - 2006/9

Y1 - 2006/9

N2 - Focal Points ■ Pharmacists’ reasons for not being in favour of the over-the-counter (OTC) statin were multifactorial and provide indications of how their misgivings might be addressed ■ Provision of a satisfactory and convincing evidence base might improve acceptance by the pharmaceutical community, of future prescription – only medicine (POM) to pharmacy medicine (P) switches

AB - Focal Points ■ Pharmacists’ reasons for not being in favour of the over-the-counter (OTC) statin were multifactorial and provide indications of how their misgivings might be addressed ■ Provision of a satisfactory and convincing evidence base might improve acceptance by the pharmaceutical community, of future prescription – only medicine (POM) to pharmacy medicine (P) switches

U2 - 10.1211/096176706778387161

DO - 10.1211/096176706778387161

M3 - Article

SN - 2042-7174

VL - 14

SP - B49-B50

JO - International Journal of Pharmacy Practice

JF - International Journal of Pharmacy Practice

IS - S2

ER -

Counter prescription of simvastatin: the views of community pharmacists

Abstract

Access to Document

Fingerprint

Cite this